An effortlessly easy to use app and web-based ePRO technology supporting 'bring your own device' (BYOD) or device provisioning study models.
We built our ePRO module from the ground up to underpin late-phase, real-world, and decentralized research and promote patient engagement and data quality.
Fully integrated, all-in-one ePRO solution
The ePRO tool is fully integrated within the Baseline Plus platform, allowing you to capture clinical assessment data and direct from patient data within a single database – enabling streamlined oversight and better insights from combined reporting.
Intuitive interface to promote patient engagement
The intuitive interface offers both web and app-based data entry with automated notifications and reminders to promote better patient compliance and more comprehensive data capture.
Fast, straightforward delivery
We design and deploy our ePRO solution quickly and effortlessly, drawing on our decades of experience in late-phase and real-world research. Our expert study design team has a track record of success building commonly used PRO questionnaires with a suite of established templates.
Baseline Plus is a data capture platform uniquely designed to meet the challenges of real-world, late phase, and decentralized research. Easy to use for physicians, patients, and study managers, its tools and workflows incorporate ePRO, eConsent and electronic data capture to support any real-world, late phase design.
Case Studies
How Cisiv helped accelerate a Medical Diagnostic Validation study to obtain regulatory clearance
Cisiv partnered with a specialist CRO and a Medical Device Company (IVD Sponsor) to conduct an end-to-end process for clinical evaluation of an In Vitro Diagnostic (IVD) classed as a Rapid Diagnostic Test (RDT). This enabled the IVD Sponsor to obtain Emergency Use Authorization (EUA) during the Covid19 pandemic in an exceptionally short time frame.
Delivering vital therapies to patients through Expanded Access Programs
Designing a data capture tool for a multi-national Expanded Access Program to manage a CRO’s use of their biotechnology customer’s new product for critically ill COVID-19 patients.
Flexibility and scalability are cornerstones of real world data capture
Nadia Mahmood, PhD, is Real World Studies Director at Cisiv. Nadia has
designed and delivered systems for a wide variety of studies, including
global post-approval safety, health outcome, registries, and post-
marketing. As a subject matter expert on eCRF and study design for
observational research, Nadia helps sponsor and CRO clients succeed in
data collection and analysis for real world studies.
Seven common late phase research challenges and how to solve them
The importance of having the right tool for any job is very pertinent to the
late phase space and reminds me of the saying, ”if your only tool is a hammer,
every problem looks like a nail”. This also neatly expresses how not having the
the correct tool to address any given challenge can discourage and disengage
stakeholders to proceed in solving the problem.
The rise of decentralised and real world research during COVID-19
For years, the prospect of ‘virtual’ and decentralised research was discussed with hope as a potential disruptor to enable greater patient access and engagement